| P2093 | author name string | Lei Yuan | |
| | Haiying Yan | |
| | Cuixiang Yu | |
| | Shujuan Sun | |
| | Mengjiao Lu | |
| P2860 | cites work | Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008-2013: results from population-based surveillance | Q28545137 |
| | Synergistic Effect of Fluconazole and Calcium Channel Blockers against Resistant Candida albicans | Q28550850 |
| | Surface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance | Q31136813 |
| | Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity | Q33602928 |
| | Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole | Q33622915 |
| | Potential role of phospholipases in virulence and fungal pathogenesis | Q33812431 |
| | Invasive Candidiasis | Q34497221 |
| | The Missing Link between Candida albicans Hyphal Morphogenesis and Host Cell Damage | Q34543128 |
| | In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms | Q35152853 |
| | Evidence implicating phospholipase as a virulence factor of Candida albicans | Q35412896 |
| | Larva of the greater wax moth, Galleria mellonella, is a suitable alternative host for studying virulence of fish pathogenic Vibrio anguillarum | Q35670991 |
| | Evaluation of Galleria mellonella larvae for studying the virulence of Streptococcus suis. | Q36225608 |
| | Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection | Q36370514 |
| | Antagonism of Fluconazole and a Proton Pump Inhibitor against Candida albicans | Q36571941 |
| | Black oesophagus | Q36703558 |
| | Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma: Case Report | Q36822926 |
| | Yeast ATP-binding cassette transporters conferring multidrug resistance | Q38019037 |
| | The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012. | Q38025819 |
| | Recent insights into Candida albicans biofilm resistance mechanisms | Q38131290 |
| | Efflux pump proteins in antifungal resistance | Q38249178 |
| | The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans | Q38626885 |
| | Probiotic lactobacilli inhibit early stages of Candida albicans biofilm development by reducing their growth, cell adhesion, and filamentation. | Q39844093 |
| | Candida Infections and Human Defensins. | Q40092614 |
| | Galleria mellonella as an in vivo model for assessing the protective activity of probiotics against gastrointestinal bacterial pathogens | Q40267485 |
| | Activity of Sanguinarine against Candida albicans Biofilms | Q40323046 |
| | The Synergistic Effect of Azoles and Fluoxetine against Resistant Candida albicans Strains Is Attributed to Attenuating Fungal Virulence | Q41194566 |
| | Galleria mellonella as an in vivo model for assessing the efficacy of antimicrobial agents against Enterobacter cloacae infection | Q41483225 |
| | Proton-pump inhibitors: understanding the complications and risks | Q41996131 |
| | Morphogenesis control in Candida albicans and Candida dubliniensis through signaling molecules produced by planktonic and biofilm cells | Q42130161 |
| | Potent drugs that attenuate anti-Candida albicans activity of fluconazole and their possible mechanisms of action. | Q42206797 |
| | Combinatory effect of fluconazole and FDA-approved drugs against Candida albicans | Q42257229 |
| | Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression | Q42371575 |
| | Esophageal candidiasis in an immunocompetent girl | Q43283458 |
| | Inhibition of hyphal growth of Candida albicans by activated lansoprazole, a novel benzimidazole proton pump inhibitor | Q43669050 |
| | Correlation between phospholipase of Candida albicans and resistance to fluconazole | Q44931075 |
| | Phospholipase and proteinase activities of Candida spp. isolates from vulvovaginitis in Iran | Q46499411 |
| | Exogenous tyrosol inhibits planktonic cells and biofilms of Candida species and enhances their susceptibility to antifungals | Q46755845 |
| | In vivo activity of fluconazole/tetracycline combinations in Galleria mellonella with resistant Candida albicans infection | Q47694828 |
| | Acid suppression therapy as a risk factor for Candida esophagitis. | Q50881044 |
| | Techniques for antifungal susceptibility testing of Candida albicans biofilms. | Q53857154 |
| | The role and relevance of phospholipase D1 during growth and dimorphism of Candida albicans | Q61441059 |
| | A rare case report of fungal esophagitis combined with giant gastric ulcer in an immunocompetent patient | Q64235218 |
| | Synergy, antagonism, and what the chequerboard puts between them | Q73521098 |
| | Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms | Q82943372 |
| | A D-octapeptide drug efflux pump inhibitor acts synergistically with azoles in a murine oral candidiasis infection model | Q83161865 |
| | Five-Year National Surveillance of Invasive Candidiasis: Species Distribution and Azole Susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study | Q88618214 |
| | Reversal of Azole Resistance in Candida albicans by Sulfa Antibacterial Drugs | Q89698018 |
| | A Dire Presentation of Diabetic Ketoacidosis with "Black Esophagus | Q92298537 |
| P433 | issue | 1 | |
| P921 | main subject | Candida albicans | Q310443 |
| | fluconazole | Q411478 |
| P304 | page(s) | 498 | |
| P577 | publication date | 2020-01-16 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Proton pump inhibitors act synergistically with fluconazole against resistant Candida albicans | |
| P478 | volume | 10 | |